NR1I2 and cancer: The activation of transcription factors such as aryl hydrocarbon receptor (AhR) and pregnane X receptor (PXR), which regulate the CYP450 enzymes (CYP1A2, CYP1A2, and CYP3A4), can further induce immunosuppression, cancer, and alter drug toxicity.